Page last updated: 2024-09-03

desloratadine and Obesity

desloratadine has been researched along with Obesity in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alpini, GD; Alpini, SF; Du, C; Francis, H; Gashev, AA; Gasheva, OY; Gobbell, C; Hargrove, L; Hitt, AR; Meininger, CJ; Newell-Rogers, MK; Pal, S; Troyanova-Wood, M; Tsoy Nizamutdinova, I; Yakovlev, VV; Zawieja, DC1

Other Studies

1 other study(ies) available for desloratadine and Obesity

ArticleYear
Prolonged intake of desloratadine: mesenteric lymphatic vessel dysfunction and development of obesity/metabolic syndrome.
    American journal of physiology. Gastrointestinal and liver physiology, 2019, 01-01, Volume: 316, Issue:1

    Topics: Adipose Tissue; Animals; Fatty Liver; Insulin Resistance; Lipids; Loratadine; Lymphatic Vessels; Male; Metabolic Syndrome; Obesity; Rats; Rats, Sprague-Dawley; Weight Gain

2019